Status:

COMPLETED

Association of Constipation Inflammatory and Microbial Translocation Markers

Lead Sponsor:

Tungs' Taichung Metroharbour Hospital

Conditions:

Constipation

Inflammation

Eligibility:

All Genders

20-90 years

Brief Summary

Growing evidences showed that patients with chronic constipation accompanied with intestinal dysbiosis. Gut dysbiosis is a harbinger of chronic inflammation, yet the underlying basis is unclear. Plasm...

Detailed Description

Study Design and Population Patients and methods 2.1. Patient selection Two hundred hemodialysis patients are recruited. Functional constipation will be diagnosed according to the Rome IV criteria. O...

Eligibility Criteria

Inclusion

  • Hemodialysis for more than 3 months and Age older than 20 years old

Exclusion

  • he exclusion criteria are a history of chronic inflammatory disease, the presence of current infection, collagen vascular disease or immuno-modulatory or immuno-suppressive treatment.

Key Trial Info

Start Date :

March 10 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2020

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04307121

Start Date

March 10 2020

End Date

December 31 2020

Last Update

February 1 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tungs' Taichung MetroHarbour Hospital

Taichung, Taiwan